What is the exact US filing date for Apotex’s ruxolitinib?
Apotex’s ruxolitinib US filing date is not provided in the information available to me here, so I can’t state an exact date without a supporting record (for example, a specific FDA submission number, patent publication, or Drugs@FDA listing that includes the filing date).
If you share one of the following, I can pinpoint the exact filing date from the underlying document:
- the NDA/ANDA/BLA number (or application type) for Apotex’s ruxolitinib, or
- the relevant patent/publication number (e.g., WO/US publication), or
- a link to the specific Drugs@FDA page or patent record you’re looking at.
Where to check the exact date (and what to look for)
To find the “exact filing date,” you typically need to look at the specific FDA or patent record that states the filing date (not just approval dates). Two common sources are:
- FDA’s Drugs@FDA entry for the relevant application, which often lists key dates tied to the application, and
- the patent or exclusivity record tied to the product, which usually includes filing/publication metadata.
If you want, I can verify it quickly
Send the application identifier you have (ANDA number, for example) or the document link, and I’ll extract the exact filing date for Apotex’s ruxolitinib in the US.